The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chronic health conditions (CHCs) following cisplatin-based chemotherapy (CHEM): A multi-institutional study of 680 testicular cancer survivors (TCS).
 
Mohammad Issam Abu Zaid
No Relationships to Disclose
 
Howard D. Sesso
Research Funding - Pfizer (Inst)
 
Chunkit Fung
Stock and Other Ownership Interests - GlaxoSmithKline
Consulting or Advisory Role - Dendreon; Janssen Scientific Affairs
Research Funding - Astellas Pharma (Inst)
 
Darren Richard Feldman
Consulting or Advisory Role - Bayer; Gilead Sciences (I)
Research Funding - Novartis
 
Robert James Hamilton
No Relationships to Disclose
 
David J. Vaughn
No Relationships to Disclose
 
Clair Beard
No Relationships to Disclose
 
Malcolm J. Moore
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Research Funding - Aduro Biotech; Celgene
 
Deepak M. Sahasrabudhe
No Relationships to Disclose
 
Eileen Johnson
No Relationships to Disclose
 
Sophie Fossa
No Relationships to Disclose
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen; Biogen
Speakers' Bureau - Celgene; ZIOPHARM Oncology
 
Lois B. Travis
No Relationships to Disclose